NPI: 1588776645 · PHILADELPHIA, PA 19139 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/31/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 08/31/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,237 | $0.00 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 85041 | 156 | 135 | $0.00 | |
| 83970 | 48 | 48 | $0.00 | |
| 85048 | 155 | 135 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 185 | 55 | $0.00 |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 527 | 151 | $0.00 |
| 83540 | 159 | 147 | $0.00 | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 1,974 | 178 | $0.00 |
| 82108 | 20 | 19 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 173 | 173 | $0.00 |
| 82728 | 46 | 45 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,578 | 137 | $0.00 |
| 83550 | 159 | 147 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 36 | 18 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 21 | 19 | $0.00 |